These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10069377)

  • 1. Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro.
    Litovchick A; Evdokimov AG; Lapidot A
    FEBS Lett; 1999 Feb; 445(1):73-9. PubMed ID: 10069377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside-arginine conjugates that bind TAR RNA: synthesis, characterization, and antiviral activity.
    Litovchick A; Evdokimov AG; Lapidot A
    Biochemistry; 2000 Mar; 39(11):2838-52. PubMed ID: 10715103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
    Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of ethidium-arginine conjugates directed against the TAR RNA of HIV-1.
    Peytou V; Condom R; Patino N; Guedj R; Aubertin AM; Gelus N; Bailly C; Terreux R; Cabrol-Bass D
    J Med Chem; 1999 Oct; 42(20):4042-53. PubMed ID: 10514274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.
    Das I; Désiré J; Manvar D; Baussanne I; Pandey VN; Décout JL
    J Med Chem; 2012 Jul; 55(13):6021-32. PubMed ID: 22698070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription.
    Lapidot A; Berchanski A; Borkow G
    FEBS J; 2008 Nov; 275(21):5236-57. PubMed ID: 18803669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.
    Hamy F; Felder ER; Heizmann G; Lazdins J; Aboul-ela F; Varani G; Karn J; Klimkait T
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3548-53. PubMed ID: 9108013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B; Wainberg MA; Frankel AD
    J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
    Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
    Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
    Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region.
    Xie B; Invernizzi CF; Richard S; Wainberg MA
    J Virol; 2007 Apr; 81(8):4226-34. PubMed ID: 17267505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry.
    Daelemans D; Schols D; Witvrouw M; Pannecouque C; Hatse S; van Dooren S; Hamy F; Klimkait T; de Clercq E; VanDamme AM
    Mol Pharmacol; 2000 Jan; 57(1):116-24. PubMed ID: 10617686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
    Calnan BJ; Biancalana S; Hudson D; Frankel AD
    Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
    Lapidot A; Vijayabaskar V; Litovchick A; Yu J; James TL
    FEBS Lett; 2004 Nov; 577(3):415-21. PubMed ID: 15556620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
    Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
    Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Rhim H; Rice AP
    Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protein synthesis by aminoglycoside-arginine conjugates.
    Carriere M; Vijayabaskar V; Applefield D; Harvey I; Garneau P; Lorsch J; Lapidot A; Pelletier J
    RNA; 2002 Oct; 8(10):1267-79. PubMed ID: 12403465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.